|Table of Contents|

Research progress on the relationship between imaging features and clinical and pathological features of breast microcalcification

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 24
Page:
4650-4653
Research Field:
Publishing date:

Info

Title:
Research progress on the relationship between imaging features and clinical and pathological features of breast microcalcification
Author(s):
SONG Fugui; ZHANG Qi; LYU Zhehao; CHEN Ying
Department of Radiology,the First Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150001,China.
Keywords:
breast cancer; breast calcification; pathological features
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2023.24.033
Abstract:
As a common female malignant tumor,breast cancer has the characteristics of heterogeneous tumor.Malignant calcification of breast cancer is one of the common imaging features of breast cancer,which plays an important role in the screening,treatment and prognosis of breast cancer.The imaging,pathological and clinical features of breast cancer are the key indicators and recognized criteria to determine the treatment and prognosis of breast cancer.The study of imaging and clinicopathological features of malignant calcification in breast cancer is of great significance for the further understanding of the cause and mechanism of calcification.By reviewing the recent studies on malignant calcification of breast cancer,this paper summarizes the relationship between the formation of breast microcalcification,imaging features and clinicopathological features.

References:

[1]WHO.Breast cancer:prevention and control［database on the Internet］［Z］.WHO,2017,11(1):ed70-ed71.https://www.who.int/cancer/events/breast_cancer_month/zh/.DOI:10.3332/ecancer.2017.ed70.
[2] BALDWIN P.Breast calcification imaging［J］.Radiol Technol,2013,84(4):383M-408M.
[3]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范（2019年版）［J］.中国癌症杂志,2019,29(08):609-680. Breast Cancer Professional Committee of China Anti-Cancer Association.Guidelines and norms for diagnosis and treatment of Breast Cancer of China Anti-Cancer Association (2019 Edition)［J］.Chinese Journal of Cancer,2019,29(08):609-680.
[4]KIM JH,EUN SK,KIM DY,et al.Noncalcified ductal carcinoma in situ imaging and histologic findings in 36 tumors［J］.J Ultras Med,2009,28(7):903-910.
[5]GRIMM LJ,GHATE SV,HWANG ES,et al.Imaging features of patients undergoing active surveillance for ductal carcinoma in situ［J］.Acad Radiol,2017,24(11):1364-1371.
[6]VANNA R,MORASSO C,MARCINN B,et al.Raman spectroscopy reveals that biochemical composition of breast microcalcifications correlates with histopathologic features［J］.Cancer Res,2020,80(8):1762-1772.
[7]GRIMM LJ,MILLER MM,THOMAS SM,et al.Growth dynamics of mammographic calcifications:differentiating ductal carcinoma in situ from benign breast disease［J］.Radiology,2019,292(1):77-83.
[8]GHAMMRAOUI B,BADER S,THUERING T,et al.Classification of breast microcalcifications with GaAs photon-counting spectral mammography using an inverse problem approach［J］.Biomed Phys Eng Express,2023,9(3):2304-2311.
[9] MORGAN MP,COOKE MM,MCCARTHY GM.Microcalcifications associated with breast cancer:an epiphenomenon or biologically significant feature of selected tumors［J］.J Mammary Gland Biol Neoplasia,2005,10(2):181-187.
[10]GOSLING S,CALABRESE D,NALLALA J,et al.A multi-modal exploration of heterogeneous physico-chemical properties of DCIS breast microcalcifications［J］.Analyst,2022,147(8):1641-1654.
[11]YAMADA T,MORI N,WATANABE M,et al.Radiologic-pathologic correlation of ductal carcinoma in situ［J］.Radiographics,2010,30(5):1183-1198.
[12]CROSS BM,BREITWIESER GE,REINHARDT TA,et al.Cellular calcium dynamics in lactation and breast cancer:from physiology to pathology［J］.Am J Physiol Cell Physiol,2014,306(6):C515-526.
[13]SCIMECA M,BONFIGLIO R,MENICHINI E,et al.Microcalcifications drive breast cancer occurrence and development by macrophage-mediated epithelial to mesenchymal transition［J］.Int J Mol Sci,2019,20(22):5633-5651.
[14]YOUK JH,GWEON HM,SON EJ,et al.Scoring system to stratify malignancy risks for mammographic microcalcifications based on breast imaging reporting and data system 5th edition descriptors［J］.Korean J Radiol,2019,20(12):1646-1652.
[15]RAO AA,FENEIS J,LALONDE C,et al.A pictorial review of changes in the BI-RADS fifth edition［J］.Radiographics,2016,36(3):623-639.
[16] AVDAN ASLAN A,GLTEKIN S,ESENDAGLI YILMAZ G,et al.Is there any association between mammographic features of microcalcifications and breast cancer subtypes in ductal carcinoma in situ［J/OL］.Acad Radiol,2020,30(20):S1076-6332(20)30339-1［2020-06-30］.https://pubmed.ncbi.nlm.nih.gov/32620528/.DOI:10.1016/j.acra.2020.05.032.Epub ahead of print.
[17]KIM J,KIM EK,KIM MJ,et al."Category 4A" microcalcifications:how should this subcategory be applied to microcalcifications seen on mammography［J］.Acta Radiol,2018,59(2):147-153.
[18]BERG WA,GUTIERREZ L,NESSAIVER MS,et al.Diagnostic accuracy of mammography,clinical examination,US,and MR imaging in preoperative assessment of breast cancer［J］.Radiology,2004,233(3):830-849.
[19] HU Y,ZHANG Y,CHENG J.Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer［J］.Oncol Lett,2019,18(4):4056-4063.
[20] CHEN S,GUAN X,SHU Z,et al.A new application of multimodality radiomics improves diagnostic accuracy of nonpalpable breast lesions in patients with microcalcifications-only in mammography［J］.Med Sci Monit,2019,25(3):9786-9793.
[21] CHEN W,QIN G,XU W,et al.Pathological and mammographic findings of microcalcification in calcified breast carcinoma without a mass［J］.Journal of Southern Medical University,2014,34(4):523-527.
[22]MA W,ZHAO Y,JI Y,et al.Breast cancer molecular subtype prediction by mammographic radiomic features［J］.Acad Radiol,2019,26(2):196-201.
[23]BAE MS,MOON WK,CHANG JM,et al.Mammographic features of calcifications in DCIS:correlation with oestrogen receptor and human epidermal growth factor receptor 2 status［J］.Eur Radiol,2013,23(8):2072-2078.
[24] ZHENG K,TAN JX,LI F,et al.Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China:a retrospective multi-center study of 7317 female patients［J］.Breast Cancer Res Treat,2017,166(2):569-582.
[25]BENNANI-BAITI B,BALTZER PA.MR imaging for diagnosis of malignancy in mammographic microcalcifications:a systematic review and meta-analysis［J］.Radiology,2017,283(3):692-701.
[26] RAUCH GM,HOBBS BP,KUERER HM,et al.Microcalcifications in 1657 patients with pure ductal carcinoma in situ of the breast:correlation with clinical,histopathologic,biologic features,and local recurrence［J］.Ann Surg Oncol,2016,23(2):482-489.
[27] LI Y,CAO J,ZHOU Y,et al.Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer［J］.Sci Rep,2019,9(1):10544-10553.
[28]ZHOU W,SOLLIE T,TOT T,et al.Ductal breast carcinoma in situ:mammographic features and its relation to prognosis and tumour biology in a population based cohort［J］.Int J Breast Cancer,2017,2017(5):4351319-4351328.
[29]QI X,CHEN A,ZHANG P,et al.Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery［J］.Oncol Lett,2017,14(1):79-88.
[30]WOODARD GA,PRICE ER.Qualitative radiogenomics:association between BI-RADS calcification descriptors and recurrence risk as assessed by the oncotype DX ductal carcinoma in situ score［J］.Am J Roentgenol,2019,212(4):919-924.
[31] WANG K,ZHANG X,ZHENG K,et al.Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients:Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT)［J］.Medicine (Baltimore),2018,97(28):e11296-e11306.
[32] CEN D,XU L,ZHANG S,et al.BI-RADS 3-5 microcalcifications:prediction of lymph node metastasis of breast cancer［J］.Oncotarget,2017,8(18):30190-30198.

Memo

Memo:
-
Last Update: 1900-01-01